Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Alembic Pharma Moves Gujarat HC Against Rs 42.16 Crore Power Utility Invoices

Alembic Pharma Moves Gujarat HC Against Rs 42 Crore Power Utility Invoices

Written By Susmita Roy20 Dec 2025 4:37 PM IST

New Delhi: Alembic Pharmaceuticals has approached the Gujarat High Court challenging supplementary invoices amounting to over Rs 42 crore issued by...

Misuse of ORS Label: FSSAI Issues 75 Notices to FBOs for Non-WHO Compliant Drinks

Written By Susmita Roy20 Dec 2025 4:00 PM IST

Misuse of ORS Label:

Roxithromycin NSQ Case: Telangana HC Slams CDSCO for Mindless Prosecution

Aurobindo Pharma Gets HC Relief in Compensation Cess Refund Dispute, GST Orders Quashed

Written By Susmita Roy19 Dec 2025 3:15 PM IST

New Delhi: In a major relief to Aurobindo Pharma regarding the refund of compensation cess paid on coal used to manufacture medicines for export, the...

Same Quality, 14X Price: Study Finds No Difference Between Branded and Generic Drugs

Generic Medicine Production Rises 26% to Rs 4.06 Lakh Cr in Three Years, Parliament Informed

Written By Susmita Roy18 Dec 2025 3:32 PM IST

New Delhi: Despite the absence of separate production data for generic medicines, the total value of medicines produced in India surged by 26% over...

Rajasthan Flags 7 Drug Batches Including Cefixime, Albendazole, Ciprofloxacin as NSQ, Orders Recall

Over 14,300 Drug Samples Fail Quality Tests in Five Years: Minister

Written By Susmita Roy18 Dec 2025 2:55 PM IST

New Delhi: Over the last five years, drug regulators tested more than 4.9 lakh samples of medicines, including cough syrups, ORS, protein powders, and...

AI Meets Pharma: Novo Nordisk Teams Up with OpenAI for Faster Drug Innovation

Novo Nordisk Gets CDSCO Panel Nod to Conduct India-Specific PMS Studies on Somapacitan

Written By Susmita Roy17 Dec 2025 9:04 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Novo Nordisk India...

Health Ministry Proposes Mandatory Disclosure of Sterilisation Site Licence on Device Labels

Health Ministry Proposes Perpetual Validity for Medical Device Licences

Written By Susmita Roy17 Dec 2025 1:15 PM IST

New Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare (Department of Health and Family Welfare) has issued a...

Diabetes Drug Bladder Cancer Risk Debate: Madras HC Orders Expert Review on Pioglitazone, Sitagliptin Safety

Written By Susmita Roy16 Dec 2025 3:30 PM IST

New Delhi: The Madras High Court has directed the Union Ministry of Health and Family Welfare to constitute a team of medical experts to examine the...

NPPA Panel Recommends 5-Year Price Control Exemption for Intas Clozapine ER Capsules

NPPA Uses Pharma Sahi Daam App to Track Drug Price Violations, Parliament Informed

Written By Susmita Roy16 Dec 2025 1:45 PM IST

New Delhi: Drug price violations are also tracked through NPPA's Pharma Sahi Daam mobile app, allowing consumers to check prices and lodge complaints,...

Contract Pharmacists Protest at SMS Medical College, Demand Reinstatement, Recruitment Probe

Parliamentary Panel Raps DoP, NPPA for 5-Year Delay in Trade Margin Rationalisation Under DPCO

Written By Susmita Roy15 Dec 2025 8:30 PM IST

New Delhi: A parliamentary committee has expressed concern over the prolonged delay in formalizing a Trade Margin Rationalization (TMR) framework...

Wockhardt Gets Expert Panel Nod for Phase III Study of Recombinant Insulin Aspart

Written By Susmita Roy15 Dec 2025 2:45 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to...

CDSCO Panel Seeks Revised Phase IV Study for Zydus' Empagliflozin, Metformin FDC

Written By Susmita Roy15 Dec 2025 1:30 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), has asked Zydus Healthcare...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok